EpicaPatch

**EpicaPatch** is an investigational epicardial regenerative cardiac therapy developed by **Regencor** for use during surgical coronary revascularization, particularly coronary artery bypass grafting after myocardial infarction. It consists of a **compressed bioabsorbable collagen matrix** loaded with **human follistatin-like 1 protein** in a hypoglycosylated or recombinant form and is fixed onto the epicardial surface over the infarct zone at the time of surgery. The product is designed as a **sustained-release protein biologic patch** intended to promote myocardial regeneration, improve contractile function, reduce scar burden, and prevent progression to heart failure after ischemic injury.

Brand names

EpicaPatch

Other names

rhFSTL1-containing collagen matrixrhFSTL-1-containing collagen matrixrhFSTL 1-containing collagen matrixhgFSTL1-containing compressed collagen matrixhgFSTL-1-containing compressed collagen matrixhgFSTL 1-containing compressed collagen matrixbioabsorbable rhFSTL1-containing collagen matrixepicardial biopharmaceutical